- Home>
- Specialty Care>
- Oncology and Hematology>
- Anemia
Search for Anemia in Oncology and Hematology
Physician-authored summaries on the latest research on anemia, editorials on anemia, and perspectives on anemia - drawn from the top medical journals.
You searched for: anemia Items 1 to 16 of 16 results
Sort by:
- Relevance
- Date
-
Risk Factors for Pulmonary Hypertension in Sickle Cell Patients
- July 8, 2008
- David Green, MD, PhD
Genetic variants in SCD patients were associated with PH.- Covering:
- Ashley-Koch AE et al., Blood 2008 Jun 15; 111:5721.
-
Plugging the Leak in Sickle Cells
- May 6, 2008
- David Green, MD, PhD
Treatment with senicapoc, a Gardos-channel inhibitor, was associated with increased hemoglobin levels and attenuated cell dehydration and hemolysis in sickle cell patients.- Covering:
- Ataga KI et al., Blood 2008 Apr 15; 111:3991.
- Joiner CH., Blood 2008 Apr 15; 111:3918.
-
Darbepoetin for Anemia of Cancer
- March 18, 2008
- Barbara A. Murphy, MD
In an international study, researchers failed to demonstrate a significant benefit for ESAs in patients with AoC who were not receiving myelosuppressive chemotherapy or radiotherapy.- Covering:
- Smith RE Jr et al., J Clin Oncol 2008 Mar 1; 26:1040.
-
Treatment of Aplastic Anemia
- October 16, 2007
- David Green, MD, PhD
Adding G-CSF to standard therapy (ATG plus CyA) increased the percentage of patients who responded at 6 months.- Covering:
- Teramura M et al., Blood 2007 Sep 15; 110:1756.
-
Erythropoietin in Critical Care PatientsFree!
- September 5, 2007
- David Green, MD, PhD
Among all ICU patients, need for transfusion did not change when epoetin was administered; among trauma patients, epoetin increased the 140-day survival rate.- Covering:
- Corwin HL et al., N Engl J Med 2007 Sep 6; 357:965-76.
-
Complete Correction of Anemia of Renal Failure Is Not Advised
- December 11, 2006
- David Green, MD, PhD
Target Hb levels should not exceed 12 g/dL.- Covering:
- Drüeke TB et al., N Engl J Med 2006 Nov 16; 355:2071-84.
- Singh AK et al., N Engl J Med 2006 Nov 16; 355:2085-98.
-
Hydroxyurea for Sickle Cell Disease: Coming of Age
- May 6, 2008
- David Green, MD, PhD
HU is effective but underused in U.S. patients with SCD.- Covering:
- Brawley OW et al., Ann Intern Med 2008 May 5;:
-
Venous Thrombosis in Patients with Sickle Cell Trait
- August 21, 2007
- David Green, MD, PhD
In a case-control study, sickle cell trait was twice as likely to occur in VTE patients as in controls.- Covering:
- Austin H et al., Blood 2007 Aug 1; 110:908-12.
-
Impaired Renal Function in Sickle Cell Patients
- April 30, 2007
- David Green, MD, PhD
Young sickle cell patients without overt kidney disease exhibited significantly increased creatinine clearance and albumin excretion rates compared with age-matched controls.- Covering:
- Thompson J et al., Arch Intern Med 2007 Apr 9; 167:701-8.
-
Venous Thrombosis and Occult Malignancy
- February 12, 2008
- David Green, MD, PhD
Predictors of occult malignancy among patients with VTE were older age, unprovoked VTE, bilateral DVT, and anemia.- Covering:
- Trujillo-Santos J et al., J Thromb Haemost 2008 Feb; 6:251.
-
Screening for Hemochromatosis
- April 15, 2008
- David Green, MD, PhD
Genetic testing is nonspecific and costly — an inexpensive blood test might be better.- Covering:
- Waalen J et al., Blood 2008 Apr 1; 111:3373.
-
Lenalidomide for Myelodysplasia
- January 22, 2008
- David Green, MD, PhD
About one quarter of low-risk MDS patients became transfusion independent after a median of 5 weeks of therapy.- Covering:
- Raza A et al., Blood 2008 Jan 1; 111:86.
- Estey EH., Blood 2008 Jan 1; 111:6.
-
Preventing Thromboembolism in PNH Patients
- January 8, 2008
- David Green, MD, PhD
Is eculizumab effective?- Covering:
- Hillmen P et al., Blood 2007 Dec 1; 110:4123.
- Rosse WF., Blood 2007 Dec 1; 110:3821.
-
Cardiovascular Disease Following Stem-Cell Transplantation
- November 20, 2007
- David Green, MD, PhD
Adverse arterial events were significantly more common among allogeneic HSCT recipients than among autologous recipients.- Covering:
- Tichelli A et al., Blood 2007 Nov 1; 110:3463.
-
Assessing Risk for Progression in Smoldering MyelomaFree!
- June 20, 2007
- Michael E. Williams, MD
SM patients at the highest risk might benefit from therapy to prevent overt myeloma.- Covering:
- Kyle RA et al., N Engl J Med 2007 Jun 21; 356:2582-90.
-
ADAMTS13 and Thrombotic MicroangiopathyFree!
- May 7, 2007
- David Green, MD, PhD
High antibody titers and persistence of undetectable ADAMTS13 activity during remission indicate poor prognosis and predict relapse.- Covering:
- Ferrari S et al., Blood 2007 Apr 1; 109:2815-22.
- Prev
- 1
- Next
You searched for: anemia Items 1 to 16 of 16 results